Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- In people with chronic idiopathic thrombocytopenic purpura, what are the benefits and harms of thrombopoietin (TPO) receptor agonists?
Use of this content is subject to our disclaimer